Hello there, welcome to Haaba! As you browse through the site, please feel free to send us your feedback (or bug reports). We'll be glad to hear from you.
STOCKHOLM, July 28, 2008 (AFP) - Lung cancer has become the deadliest form of cancer among women in Sweden, overtaking breast cancer, Sweden's National Board of Health and Welfare said in a report published Monday.
CHICAGO, July 21, 2008 (AFP) - Researchers have developed a plant-based cancer vaccine capable of kick-starting the body's immune response and being tailored to a patient's specific tumor type, according to a study released Monday.
PARIS, July 16, 2008 (AFP) - The United States holds the best overall record for surviving cancer, despite a large disparity between American blacks and whites, while Algeria has the worst, according to a study of 31 countries published on Thursday.
PARIS, July 3, 2008 (AFP) - A new kidney cancer vaccine failed in last-phase clinical trials to improve the odds of avoiding remission after tumour-removing surgery, according to a study released Friday.
WASHINGTON, July 2, 2008 (AFP) - A scientific study published here Wednesday sheds light on why men who eat a lot of broccoli are less likely to develop prostate cancer.
PARIS, July 1, 2008 (AFP) - Oral and nasal snuff and chewing tobacco increase the risk of certain types of cancer but are probably safer than smoking, according to a review published on Wednesday in the journal Lancet Oncology.
The risk of throat and pancreatic cancer is roughly 60 percent higher among users of smokeless tobacco products compared with non-users, it found.
CHICAGO, June 3, 2008 (AFP) - An experimental vaccine designed to treat the most common and deadly brain tumor has more than doubled the survival of patients, according to results of a small clinical study released on Monday.
The vaccine, produced by the US firm Avant Immunotherapeutics Inc, stimulates the immune system to attack the glioblastoma multiforme (GBM) tumor.
CHICAGO, June 2, 2008 (AFP) - The cancer drug Erbitux prolonged the lives of patients with advanced lung cancer by five weeks, according to a new clinical study described as an important gain for such individuals.
CHICAGO, June 2, 2008 (AFP) - The cancer drug Erbitux (cetuximab) prolonged the lives of patients with advanced lung cancer by five weeks, according to a clinical study described Sunday as an important gain for such individuals.
CHICAGO, June 1, 2008 (AFP) - New drug cocktails have shown promise in the fight against breast cancer, a diseases that annually kills more than half an million of women around the world, two new studies show.
The research was unveiled at an annual meeting here of the American Society of Clinical Oncology.